These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1242372)

  • 21. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
    Rodríguez FD; Rodríguez RE
    Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of injection of 5,6-dihydroxytryptamine to the dorsal raphe nucleus on carbachol-induced defensive behavior and regional brain amine content in the cat.
    Romaniuk A; Filipczak M; Fryczak J
    Pol J Pharmacol Pharm; 1987; 39(1):17-25. PubMed ID: 2444950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
    Mefford IN; Roth KA; Jurik SM; Collman V; McIntire S; Tolbert L; Barchas JD
    Brain Res; 1985 Jul; 339(2):342-5. PubMed ID: 2411347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 29. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine.
    Diaz J; Ellison G; Masuoka D
    Psychopharmacologia; 1974 Jun; 37(1):67-79. PubMed ID: 4414929
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of 5,6-dihydroxytryptamine and its benzo[b]-thiophene analogue on biogenic amines in the rat.
    Donelson AC; Bosin TR; Campaigne E; Rogers RB; Maickel RP
    Biochem Pharmacol; 1979 Nov; 28(22):3339-43. PubMed ID: 526340
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a role of the locus coeruleus noradrenaline system in learning.
    Ogren SO; Archer T; Ross SB
    Neurosci Lett; 1980 Dec; 20(3):351-6. PubMed ID: 7443081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gas chromatographic analysis of central biogenic amines and its application. 1].
    Maruyama Y; Hosoya E; Takemori AE
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):661-72. PubMed ID: 4271692
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.
    Johnson PL; Molosh A; Fitz SD; Arendt D; Deehan GA; Federici LM; Bernabe C; Engleman EA; Rodd ZA; Lowry CA; Shekhar A
    Pharmacol Biochem Behav; 2015 Nov; 138():174-9. PubMed ID: 26476009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 6-hydroxydopamine, 5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats.
    Bläsig J; Reinhold K; Herz A
    Psychopharmacologia; 1973 Jul; 31(2):111-9. PubMed ID: 4578906
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioral effects of neurotoxic lesions of the ascending monoamine pathways in the rat brain.
    Heybach JP; Coover GD; Lints CE
    J Comp Physiol Psychol; 1978 Feb; 92(1):58-70. PubMed ID: 627639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5-hydroxytryptamine on defecation in open-field behavior in rats.
    Kameyama T; Suzuki M; Nabeshima T
    Pharmacol Biochem Behav; 1980 Jun; 12(6):875-82. PubMed ID: 6447297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.